# FOSAPREPITANT DIMEGLUMINE
> **ANDA204025** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2020-08-26
## Drug
- **FDA Application Number:** ANDA204025
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FOSAPREPITANT DIMEGLUMINE
- **Generic name:** Fosaprepitant Dimeglumine
- **Active ingredients:** FOSAPREPITANT DIMEGLUMINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** ACCORD HLTHCARE
- **First approval:** 2020-08-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204025)
---
*AI Analytics · CC0 1.0*